ASX - By Stock
|
1AI |
Re:
Ann: Approval granted for group 3 in Parkinsons trial
|
|
mjp44
|
57 |
16K |
7 |
08/02/17 |
08/02/17 |
ASX - By Stock
|
57
|
16K
|
7
|
|
ASX - By Stock
|
1AI |
Re:
Final, Group 3, Phase II Trials
|
|
mjp44
|
137 |
39K |
3 |
18/01/17 |
18/01/17 |
ASX - By Stock
|
137
|
39K
|
3
|
|
ASX - By Stock
|
1AI |
Re:
Final, Group 3, Phase II Trials
|
|
mjp44
|
137 |
39K |
5 |
12/01/17 |
12/01/17 |
ASX - By Stock
|
137
|
39K
|
5
|
|
ASX - By Stock
|
1AI |
Re:
Large sell order
|
|
mjp44
|
4 |
1.2K |
0 |
10/01/17 |
10/01/17 |
ASX - By Stock
|
4
|
1.2K
|
0
|
|
ASX - By Stock
|
1AI |
Large sell order
|
|
mjp44
|
4 |
1.2K |
1 |
10/01/17 |
10/01/17 |
ASX - By Stock
|
4
|
1.2K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Parkinsons
|
|
mjp44
|
25 |
7.6K |
1 |
13/12/16 |
13/12/16 |
ASX - By Stock
|
25
|
7.6K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Parkinsons
|
|
mjp44
|
25 |
7.6K |
1 |
11/12/16 |
11/12/16 |
ASX - By Stock
|
25
|
7.6K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Newsletter
|
|
mjp44
|
65 |
16K |
0 |
22/07/16 |
22/07/16 |
ASX - By Stock
|
65
|
16K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
big buying today
|
|
mjp44
|
25 |
7.6K |
6 |
22/06/16 |
22/06/16 |
ASX - By Stock
|
25
|
7.6K
|
6
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL demonstrates continued reversal of Parkinsons-LCT.AX
|
|
mjp44
|
136 |
36K |
2 |
10/06/16 |
10/06/16 |
ASX - By Stock
|
136
|
36K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL demonstrates continued reversal of Parkinsons-LCT.AX
|
|
mjp44
|
136 |
36K |
2 |
08/06/16 |
08/06/16 |
ASX - By Stock
|
136
|
36K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL demonstrates continued reversal of Parkinsons-LCT.AX
|
|
mjp44
|
136 |
36K |
4 |
08/06/16 |
08/06/16 |
ASX - By Stock
|
136
|
36K
|
4
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL demonstrates continued reversal of Parkinsons-LCT.AX
|
|
mjp44
|
136 |
36K |
3 |
08/06/16 |
08/06/16 |
ASX - By Stock
|
136
|
36K
|
3
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL demonstrates continued reversal of Parkinsons-LCT.AX
|
|
mjp44
|
136 |
36K |
1 |
08/06/16 |
08/06/16 |
ASX - By Stock
|
136
|
36K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL demonstrates continued reversal of Parkinsons-LCT.AX
|
|
mjp44
|
136 |
36K |
1 |
07/06/16 |
07/06/16 |
ASX - By Stock
|
136
|
36K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Appendix 3B-LCT.AX
|
|
mjp44
|
48 |
11K |
0 |
22/04/16 |
22/04/16 |
ASX - By Stock
|
48
|
11K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
A joke ....
|
|
mjp44
|
7 |
3.0K |
2 |
25/06/15 |
25/06/15 |
ASX - By Stock
|
7
|
3.0K
|
2
|
|
ASX - By Stock
|
1AI |
Re:
LCT Conference Call
|
|
mjp44
|
16 |
4.7K |
8 |
18/06/15 |
18/06/15 |
ASX - By Stock
|
16
|
4.7K
|
8
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL Clinical Study in Parkinson's Meets Endpoints
|
|
mjp44
|
116 |
21K |
3 |
17/06/15 |
17/06/15 |
ASX - By Stock
|
116
|
21K
|
3
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL Clinical Study in Parkinson's Meets Endpoints
|
|
mjp44
|
116 |
21K |
0 |
17/06/15 |
17/06/15 |
ASX - By Stock
|
116
|
21K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL Clinical Study in Parkinson's Meets Endpoints
|
|
mjp44
|
116 |
21K |
1 |
16/06/15 |
16/06/15 |
ASX - By Stock
|
116
|
21K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Ann: NTCELL Clinical Study in Parkinson's Meets Endpoints
|
|
mjp44
|
116 |
21K |
3 |
15/06/15 |
15/06/15 |
ASX - By Stock
|
116
|
21K
|
3
|
|
ASX - By Stock
|
1AI |
Re:
June announcement
|
|
mjp44
|
46 |
8.5K |
0 |
12/06/15 |
12/06/15 |
ASX - By Stock
|
46
|
8.5K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
June announcement
|
|
mjp44
|
46 |
8.5K |
1 |
11/06/15 |
11/06/15 |
ASX - By Stock
|
46
|
8.5K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
June announcement
|
|
mjp44
|
46 |
8.5K |
0 |
10/06/15 |
10/06/15 |
ASX - By Stock
|
46
|
8.5K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
Ann: CEO Remuneration
|
|
mjp44
|
9 |
1.7K |
3 |
05/06/15 |
05/06/15 |
ASX - By Stock
|
9
|
1.7K
|
3
|
|
ASX - By Stock
|
1AI |
Re:
Seeking Alpha article on Type 1 Diabetes
|
|
mjp44
|
15 |
3.7K |
0 |
15/05/15 |
15/05/15 |
ASX - By Stock
|
15
|
3.7K
|
0
|
|
ASX - By Stock
|
1AI |
June announcement
|
|
mjp44
|
46 |
8.5K |
1 |
13/05/15 |
13/05/15 |
ASX - By Stock
|
46
|
8.5K
|
1
|
|
ASX - By Stock
|
1AI |
large sell order?
|
|
mjp44
|
3 |
1.1K |
1 |
18/03/15 |
18/03/15 |
ASX - By Stock
|
3
|
1.1K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
Quite forum
|
|
mjp44
|
4 |
1.5K |
3 |
11/02/15 |
11/02/15 |
ASX - By Stock
|
4
|
1.5K
|
3
|
|
ASX - By Stock
|
1AI |
DIABECELL progress
|
|
mjp44
|
2 |
1.5K |
0 |
04/09/14 |
04/09/14 |
ASX - By Stock
|
2
|
1.5K
|
0
|
|
ASX - By Stock
|
1AI |
Re:
diacebell all systems go?
|
|
mjp44
|
4 |
1.4K |
3 |
20/05/14 |
20/05/14 |
ASX - By Stock
|
4
|
1.4K
|
3
|
|
ASX - By Stock
|
1AI |
Re:
diacebell all systems go?
|
|
mjp44
|
4 |
1.4K |
1 |
15/05/14 |
15/05/14 |
ASX - By Stock
|
4
|
1.4K
|
1
|
|
ASX - By Stock
|
1AI |
Re:
a bit quiet!
|
|
mjp44
|
6 |
2.1K |
0 |
07/04/14 |
07/04/14 |
ASX - By Stock
|
6
|
2.1K
|
0
|
|
ASX - By Stock
|
1AI |
interesting cloae
|
|
mjp44
|
1 |
673 |
5 |
17/01/14 |
17/01/14 |
ASX - By Stock
|
1
|
673
|
5
|
|
ASX - By Stock
|
1AI |
Re:
Ann: Preliminary Internal Review of Dia12 Study
|
|
mjp44
|
5 |
541 |
3 |
30/08/13 |
30/08/13 |
ASX - By Stock
|
5
|
541
|
3
|
|
ASX - By Stock
|
RCR |
Re:
rcr - lift off
|
|
mjp44
|
4 |
432 |
0 |
29/08/05 |
29/08/05 |
ASX - By Stock
|
4
|
432
|
0
|
|
ASX - By Stock
|
EIF |
Re:
announcement
|
|
mjp44
|
7 |
638 |
0 |
17/08/05 |
17/08/05 |
ASX - By Stock
|
7
|
638
|
0
|
|
ASX - By Stock
|
MMX |
Re:
news comming!!!
|
|
mjp44
|
2 |
222 |
0 |
05/08/05 |
05/08/05 |
ASX - By Stock
|
2
|
222
|
0
|
|
ASX - By Stock
|
AOV |
Re:
another all ?
|
|
mjp44
|
2 |
389 |
0 |
04/08/05 |
04/08/05 |
ASX - By Stock
|
2
|
389
|
0
|
|
ASX - By Stock
|
MIS |
Re:
nice orders
|
|
mjp44
|
3 |
282 |
0 |
28/07/05 |
28/07/05 |
ASX - By Stock
|
3
|
282
|
0
|
|
ASX - By Stock
|
NHC |
volume on market depth?
|
|
mjp44
|
1 |
218 |
0 |
22/07/05 |
22/07/05 |
ASX - By Stock
|
1
|
218
|
0
|
|
ASX - By Stock
|
GNS |
interesting chart
|
|
mjp44
|
8 |
456 |
0 |
14/07/05 |
14/07/05 |
ASX - By Stock
|
8
|
456
|
0
|
|
ASX - By Stock
|
AOV |
50¢ forecast dividend, 8% yield
|
|
mjp44
|
0 |
279 |
0 |
29/06/05 |
29/06/05 |
ASX - By Stock
|
0
|
279
|
0
|
|